IGM Biosciences, Inc. Severance Costs
IGM Biosciences, Inc. reported Severance Costs of $2.82 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2025-07-31
- IGM Biosciences, Inc. severance costs for the quarter ending 2025-06-30 was $2.82M.
- IGM Biosciences, Inc. severance costs for the quarter ending 2025-03-31 was $2.85M, a 71175.00% increase year-over-year.
- IGM Biosciences, Inc. severance costs for the quarter ending 2024-12-31 was $0.00.
- IGM Biosciences, Inc. severance costs for the quarter ending 2024-09-30 was $5.54M.
- IGM Biosciences, Inc. severance costs for fiscal 2024 was $5.54M, a 48.50% increase from fiscal 2023.
- IGM Biosciences, Inc. severance costs for fiscal 2023 was $3.73M.
| Period end | Severance Costs 3 month | Severance Costs 3 month as first filed | Severance Costs 6 month | Severance Costs 9 month | Severance Costs 12 month |
|---|---|---|---|---|---|
| 2025-06-30 | $2.82M 10-Q · filed 2025-07-31 | $5.67M 10-Q · filed 2025-07-31 | $5.67M derived: sum of 3 quarters · filed 2025-07-31 | $11.21M derived: sum of 4 quarters · filed 2025-07-31 | |
| 2025-03-31 | $2.85M 10-Q · filed 2025-05-13 | $2.85M derived: sum of 2 quarters · filed 2025-05-13 | $8.39M derived: sum of 3 quarters · filed 2025-05-13 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $5.54M derived: sum of 2 quarters · filed 2025-03-06 | $5.54M 10-K · filed 2025-03-06 | ||
| 2024-09-30 | $5.54M 10-Q · filed 2024-11-08 | $5.54M 10-Q · filed 2024-11-08 | |||
| 2024-03-31 | $4.00K 10-Q · filed 2025-05-13 | $3.70M 10-Q · filed 2024-05-08 | |||
| 2023-12-31 | $3.73M 10-K · filed 2025-03-06 |